Although selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed for prenatal depression, there exists controversy over the adverse effects of SSRI use on fetal development. Few studies have adequately isolated outcomes due to SSRI exposure and those due to maternal psychiatric conditions. Here, we directly investigated the outcomes of exposure to widely-used SSRIs fluoxetine and citalopram on the developing nervous system of Xenopus laevis tadpoles, using an integrative experimental approach. We exposed tadpoles to low doses of citalopram and fluoxetine during a critical developmental period and found that the different groups of tadpoles displayed opposing behavioral effects. While both groups showed reduced schooling behavior, the fluoxetine group showed increased seizure susceptibility and reduced startle habituation. In contrast, the citalopram treated tadpoles had decreased seizure susceptibility and increased habituation. Both groups had abnormal dendritic morphology in the optic tectum, a brain area important for all three behaviors tested.Whole-cell electrophysiological recordings of tectal neurons showed no differences in synaptic function across groups; however, tectal cells from fluoxetine-treated tadpoles had decreased voltage gated K+ currents while cells in the citalopram group had increased K+ currents. Both the behavior and electrophysiological findings indicate that cells and circuits in the fluoxetine treated optic tecta are hyperexcitable, while the citalopram group exhibits decreased excitability. Taken all together, these results show that early developmental exposure to SSRIs is sufficient to induce neurodevelopmental effects, however these effects can be complex and vary depending on the SSRI used.This may explain some of the discrepancies across human studies, and further underscores the importance of serotonergic signaling for the developing nervous system.
Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed for maternal depression, one of the most prevalent perinatal psychiatric conditions. Although the effects of maternal depression have been well‐characterized, there exists controversy over the adverse effects of SSRI use upon fetal development. Few studies have adequately isolated outcomes due to SSRI exposure and those due to maternal psychiatric conditions. Here, we narrowed our focus to investigating the outcomes of exposure to the widely‐used SSRIs fluoxetine (Prozac) and citalopram (Celexa) upon the developing nervous system through behavioral and electrophysiological assays in Xenopus laevis. Exposure concentrations and timelines in humans were translated to the X. laevis using standard dosages and dose‐response curves. Behavioral assays and whole‐cell patch‐clamp recording were performed at full maturation (stage 49). The behavioral paradigms of acoustic startle habituation and seizure susceptibility in pentylenetetrazol have established relevance to autism‐like phenotypes in X. laevis and normal neurodevelopment. Interestingly, the two SSRIs demonstrated differential abnormalities in behavior and properties of the neuron and synaptic transmission. Administration of fluoxetine during development resulted in slower habituation and increased seizure susceptibility, while exposure to citalopram led to faster habituation and decreased seizure susceptibility. We sought to explain these opposing behavioral phenotypes by whole‐cell patch‐clamp recording from the sensory‐processing tectum. We found that tectal neurons from fluoxetine‐treated animals demonstrated increased intrinsic excitability and those from citalopram‐treated animals showed decreased excitability. Moreover, citalopram‐treated neurons had increased spontaneous excitatory post‐synaptic current episodes, indicating stronger individual synaptic transmission and stronger synaptic drive. Neither group showed altered synaptic facilitation, a neurobiological mechanism related to plasticity and learning, nor an imbalance of excitatory and inhibitory projections, a circuit‐level property associated with normal neurodevelopment. These results not only support the potential role of SSRIs upon the developing brain at both the behavioral and biological levels, but complicate the discretion to administer either antidepressant. Our findings implicate the off‐target effects of fluoxetine to explain such opposing consequences, given the higher selectivity of citalopram for the serotonin reuptake transporter. Future studies will systematically probe other monoamine transporters, including those for norepinephrine and dopamine, and serotonin receptors, both of which are affected by fluoxetine. This project was funded by the American Physiological Society.Support or Funding InformationThe American Physiological SocietyThis abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.